eflornithine has been researched along with Diabetic Retinopathy in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giordano, CR | 1 |
| Roberts, R | 1 |
| Krentz, KA | 1 |
| Bissig, D | 1 |
| Talreja, D | 1 |
| Kumar, A | 1 |
| Terlecky, SR | 1 |
| Berkowitz, BA | 1 |
1 other study available for eflornithine and Diabetic Retinopathy
| Article | Year |
|---|---|
Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy.
Topics: Animals; Antioxidants; Catalase; Cell Culture Techniques; Diabetes Mellitus, Experimental; Diabetic | 2015 |